Vera Therapeutics, Inc. (VERA)
31.72
-0.58
(-1.78%)
USD |
NASDAQ |
Jun 08, 16:00
32.00
+0.28
(+0.90%)
After-Hours: 20:00
Vera Therapeutics EPS Diluted (Quarterly) : -1.693 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -0.60 |
| Revolution Medicines, Inc. | -2.291 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Vaxcyte, Inc. | -2.298 |
| CG Oncology, Inc. | -0.7123 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -121.03M |
| Total Expenses (Quarterly) | 121.03M |
| Enterprise Value | 1.794B |
| Earnings Yield | -17.48% |
| Normalized Earnings Yield | -17.48 |